News
MyChesCo on MSN31m
Traws Pharma Reports Q2 Results, Advances COVID-19 and Influenza Antiviral Programs
NEWTOWN, PA — Traws Pharma, Inc. (NASDAQ: TRAW) posted second-quarter 2025 results and outlined strategic progress on its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback